Company: BDRX
Filing Date: 2025-12-08
Form Type: F-1/A
Source: 0001214659-25-017719
Chunk: 80

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-12-08
Form: F-1/A
Chunk 80
---
 than 0.25% of the issued shares of that class, be suspended by the directors
if he fails to comply with a proper request for the disclosure of interests regarding the shares.

Change of Control

There is no specific provision
in our Articles of Association that would have the effect of delaying, deferring or preventing a change of control. We are, however, subject
to the provisions of the City Code on Takeovers and Mergers, or City Code, which contains detailed provisions regulating the timing and
manner of any takeover offer for those of the Company’s shares which confer voting rights.

| 47 |

Variation of Rights

Whenever our share capital
is divided into different classes of shares, all or any of the rights attached to any class may be varied or abrogated in such manner
(if any) as may be provided by those rights or (in the absence of any such provision) either with the consent in writing of the holders
of at least 75% of the issued shares of that class or with the authority of a special resolution passed at a separate general meeting
of the holders of the shares of that class.

Alteration of Share Capital and Repurchases

Subject to the provisions
of the Companies Act, and without prejudice to any relevant special rights attached to any class of shares, we may by ordinary resolution,
from time to time:

| · | increase our share capital by allotting and issuing new shares in accordance with our articles of association 
 and any relevant shareholder resolution;                                                                      |

| · | consolidate all or any of our share capital into shares of a larger nominal amount (i.e., par value) than 
 the existing shares;                                                                                      |

| · | subdivide any of our shares into shares of a smaller nominal amount (i.e., par value) than our existing 
 shares; or                                                                                              |

| · | redenominate our share capital or any class of share capital. |

Preemptive Rights and New Issuance of Shares

Under the Companies Act, the
issuance of equity securities (except shares held under an employees’ share scheme) that are to be paid for wholly in cash must
be offered first to the existing holders of equity securities in proportion to the respective nominal amounts (i.e., par values) of their
holdings on the same or more favorable terms, unless a special resolution to the contrary has been passed or the articles of association
otherwise provide an exclusion from this requirement (which exclusion can be for a maximum of five years